The UK is witnessing a noticeable surge in interest surrounding copyright substances. Beyond the familiar use of psilocybin and LSD, researchers and enthusiasts are increasingly focused on less-charted areas, particularly copyright and the budding cannabinoid, CBG. This burgeoning community encompasses therapeutic research into emotional healing, c